Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis
Clinical trial NCT02174627 · COMPLETED
Trial details
- NCT number
- NCT02174627
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-26
- Primary completion
- 2018-10-04
- Enrollment
- 2781
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.